Curaleaf Holdings Inc
CNSX:CURA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.62
7.71
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Curaleaf Holdings Inc
Capital Expenditures
Curaleaf Holdings Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Capital Expenditures
-$89.8m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Capital Expenditures
-$377m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
1%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Capital Expenditures
-CA$7.9m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Capital Expenditures
-$4.1m
|
CAGR 3-Years
48%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Capital Expenditures
-CA$32.1m
|
CAGR 3-Years
48%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
N/A
|
|
Curaleaf Holdings Inc
Glance View
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. The company is headquartered in Vancouver, British Columbia and currently employs 5,138 full-time employees. The company went IPO on 2015-10-22. The firm improves lives by providing cannabis for consumption. The firm and its brands, including Curaleaf and Select, provide service, product selection and accessibility across the medical and adult-use markets. The firm operates in 23 states with 123 dispensaries and 25 cultivation sites. The company focuses on populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. The firm's brands also include Curaleaf Hemp and UKU Cannabis. Curaleaf is a national retail dispensary brand in the United States, which is available in multiple states and product formats.
See Also
What is Curaleaf Holdings Inc's Capital Expenditures?
Capital Expenditures
-89.8m
USD
Based on the financial report for Sep 30, 2023, Curaleaf Holdings Inc's Capital Expenditures amounts to -89.8m USD.
What is Curaleaf Holdings Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-2%
Over the last year, the Capital Expenditures growth was 42%. The average annual Capital Expenditures growth rates for Curaleaf Holdings Inc have been -2% over the past three years .
You don't have any saved screeners yet
